Atormac
Home  -  About us  -  Editorial board  -  Search  -  Ahead of print  -  Current issue  -  Archives  -  Instructions  -  Subscribe  -  Contacts  -  Advertise - Login 
 
 
     

 Table of Contents  
ORIGINAL ARTICLE - PROSPECTIVE STUDY
Year : 2017  |  Volume : 7  |  Issue : 1  |  Page : 51-56

Using carnoy's solution in treatment of keratocystic odontogenic tumor


1 Department of Oral and Maxillofacial Surgery, Specialized Surgeries Hospital, Medical City, Baghdad, Iraq
2 Department of Oral and Maxillofacial Surgery, Al Karkh General Hospital, Baghdad, Iraq

Date of Web Publication21-Jun-2017

Correspondence Address:
Ahmed Maki Merza
Department of Oral and Maxillofacial Surgery, Al Karkh General Hospital, Baghdad
Iraq
Login to access the Email id


DOI: 10.4103/ams.ams_127_16

PMID: 28713736

Rights and Permissions
  Abstract 

Aim: The aim of this study was to assess the treatment of keratocystic odontogenic tumor using enucleation and Carnoy's solution with peripheral ostectomy. Materials and Methods: Twenty-nine patients (14 females and 15 males) with age range from 12 to 62 years were included in this study and followed up for 7 years; all the patients were treated in the Department of Oral and Maxillofacial Surgery of the Specialized Surgeries Teaching Hospital (Al-Shaheed Ghazi Al-Hariri Hospital-Medical City, Baghdad, Iraq). Enucleation followed by peripheral ostectomy and the application of Carnoy's solution is the standardized method of treatment. Results: This study showed (32.7%) unilocular radiolucency for the lesions (19.9%) as multilocular radiolucency. Furthermore, it showed that the recurrence rate by this method was 0% with a minimum neurosensory disturbance. Conclusion: The complications and morbidity originating from the application of Carnoy's solution occurred less frequently and were less serious than those associated with resection while the recurrence rate is 0% which is equal to the recurrence rate of resection.

Keywords: Carnoy's solution, keratocyst, keratocystic odontogenic tumor


How to cite this article:
Alchalabi NJ, Merza AM, Issa SA. Using carnoy's solution in treatment of keratocystic odontogenic tumor. Ann Maxillofac Surg 2017;7:51-6

How to cite this URL:
Alchalabi NJ, Merza AM, Issa SA. Using carnoy's solution in treatment of keratocystic odontogenic tumor. Ann Maxillofac Surg [serial online] 2017 [cited 2019 May 20];7:51-6. Available from: http://www.amsjournal.com/text.asp?2017/7/1/51/208634




  Introduction Top


The keratocystic odontogenic tumor (KCOT), previously known as odontogenic keratocyst, has a great deal of interest in the literatures due to its high recurrence rate, locally aggressive behavior which grow to a large size before it detects clinically, and it's characteristic histological appearance. There are many evidence that support this term, and to classify it as “a benign uni- or multi-cystic, intraosseous tumor of the odontogenic origin, and Toller, 1967 suggested that the epithelial linings of the keratocyst has intrinsic growth potential and he was the first to suggest that there was some basis for regarding it as benign neoplasm.[1],[2],[3],[4] Most KCOT recurrences can be diagnosed within the first 3 years of follow-up. In spite of the fact that many treatment modalities had been developed for the treatment of the KCOT, the risk of the morbidity and the recurrence rate is still high, and also there is always balancing between the recurrence rate and the complications that is associated with the method that has been used for the treatment of KCOT.[5],[6],[7],[8]

Enucleation with peripheral ostectomy and Carnoy's solution

Enucleation with peripheral ostectomy and Carnoy's solution technique refers to surgically husking the tumor out of the bone to remove the entire lesion without leaving any macroscopic remnant. This is followed by a reduction in peripheral bone with powered handpiece and application of Carnoy's solution. Moreover, to the best our knowledge, there is only one series in the literature consisting of 13 patients treated by this method and shows 0% recurrence rate.[9]

Carnoy's solution was first described by Cutler and Zollinger, 1933 as a treatment for cystic lesions and fistulae; also currently, its use in the treatment of unicystic ameloblastoma and in ossifying fibroma is also reported in the literature. It is also likely to penetrate cancellous spaces and thus devitalize and fix the remaining tumor cells; Carnoy's solution composed of 1 g of ferric chloride [FeCl3] dissolved in 6 ml of absolute alcohol, 3 ml of chloroform, and 1 ml of glacial acetic acid; the reformulated Carnoy's solution without chloroform is currently generally accepted because exposure to chloroform has been associated with cancer and reproductive toxicity.[10] The solution can be applied inside the cystic lesion or, more commonly, directly over the remaining bone bed after the lesion has been removed. The success of the application of this agent after enucleation was thought to be due to both of its penetration and fixation action. The usual practice is to apply Carnoy's solution with cotton applicators or ribbon gauze for 3–5 min, rinse the bony defect, and pack the wound open for healing by secondary intention. Some investigator reported some complication resulting from the use of Carnoy's solution although that some doubt still remains regarding them, this complications include infection, dehiscence, bone sequestrum formation, and neuropathy.[11],[12] Frerich et al., 1994 suggested that the application of Carnoy's solution should not exceed 3–5 min. They showed that the critical time to nerve impairment of the rabbit inferior alveolar nerve was 3–5 min, and that Carnoy's solution should not be applied directly over the nerve. It is concluded that any damage happened to the blood vessels is reversible when the exposure times are <5 min.[13],[14]

Hence, this study tried to share the experience and to assess the treatment of KCOT using enucleation and Carnoy's solution with peripheral ostectomy.


  Materials and Methods Top


The sample and materials

In this study, 29 patients (14 females and 15 males) with age range from 12 years to 62 years were included and followed for 3–6 years; all the patients were treated in the Department of Oral and Maxillofacial Surgery of the Specialized Surgeries Hospital (Al-Shaheed Ghazi Al-Hariri Hospital, Medical City, Baghdad, Iraq).

The KCOT in the mandible which is extended into the condylar and coronoid processes or near the base of the skull in the maxilla was excluded from this study, and also the Gorlin–Goltz syndrome (basal cell nevous syndrome) was also excluded from the study.

The presenting symptoms were pain, neurosensory disturbance, teeth mobility, and bony expansion. Patients were completely assessed, including history, clinical examination of the intra- and extra-oral examination, laboratory assessment, radiographic studies (plain radiographs, panoramic radiograph and computerized tomography scans according to its availability), and biopsy for each patients for histopathological studies. Once these investigations were completed, informed consent was taken, and the patient fitted for surgery, the following surgical technique performed:

  1. All the cases in theater done under general anesthesia by oral or nasal intubation while the patient in supine position, throat pack is used to avoid pulmonary aspiration, the intraoral incision is used as our approach to the KCOT using two-sided or three-sided mucuoperiosteal flap according to the site, size, and the extension of the tumor, when the incision is complete, a periosteal elevator (Howarth's periosteal elevator) is used for a full mucuoperiosteal flap reflection, a bone window was made to expose the KCOT which should be always made large enough to give a good visibility and access to the tumor
  2. Extraction for the involved teeth that showing roots resorption to facilitate tumor removal and do not leave any tumor remnants and this will lead to decrease the recurrence rate. After that, the enucleation is done [Figure 1]a and [Figure 1]b. Moreover, if the inferior alveolar nerve was exposed during the enucleation procedure, especially in the molar area of the mandible; in this case, the KCOT was carefully stripped from the nerve which was preserved and isolated with tapes [Figure 1]c
  3. Peripheral ostectomy: to reduce the bony cavity (margins) using a powered handpiece and to remove any bone spicules, septa, or scalloping in the bone, with an irrigation with normal saline
  4. Carnoy's solution application: The solution (1 g of FeCl3 dissolved in 6 ml of absolute alcohol and 1 ml of glacial acetic acid without chloroform) was applied to the bony defect for 3 min using cotton applicator or ribbon gauze (1 cm 3 in size) soaked with the solution if there is large lesion so multiple pieces of (1 cm 3 in size) prepared and inserted together. This was followed by copious irrigation with normal saline and constant suctioning [Figure 1]d-[Figure 1]f
  5. Closure: In most cases, the bismuth iodoform paraffin paste (BIPP) impregnated gauze (iodoform gauze) is inserted into the bony defect leaving a small length of this gauze outside the bony cavity to be removed after 6 days without replacement to prevent infection and support suturing if the crestal alveolar bone has been lost due to extraction. Primary healing was permitted through continuous 3/0 silk suturing [Figure 1]g and [Figure 1]h
  6. Follow-up: Regular radiographic follow-up is essential. Recurrence also evaluated during the follow-up visits (1 week, 1 month, 3 months, 6 months, 1 year, 2 years, and more) postoperatively by a clinical examination to check any clinical manifestation as that found during the first presentation and by panoramic radiography to check any new osteolytic area found in the operative site, to reevaluate it using computerized tomography and/or biopsy to confirm the recurrence.
Figure 1: (a) Intraoral approach, mucuoperiosteal flap reflection and enucleation. (b) Enucleation of the keratocystic odontogenic tumor. (c) The inferior alveolar bundle (arrow) exposed and protected to be isolated during peripheral ostectomy and the application of Carnoy's solution. (d) Carnoy's solution. (e) Application of the Carnoy's solution in the bony defect after peripheral ostectomy. (f) When the 3 min of the application is elapsed, immediately before gauze removal, showing the change in the color of the gauze due to cauterization and fixation action of the solution. (g) Before wound closure. (h) Iodoform packing then suturing

Click here to view


Statistical analysis

In this study, SPSS15 Inc. (Chicago, IL) is used for statistical analysis and Excel-10 is used for tables.

  1. Tables, descriptive numbers, percentage
  2. Inverting statistics


  • Chi-square
  • Z-test
  • P value; if P < 0.05 statistically significant.


If P = 0.05 nonsignificant.

If P < 0.001 highly significant.


  Results Top


This clinical study included 29 patients, 15 (51, 72%) males and 14 (48.27%) females and with age ranging from 12 to 62 years. The mandible was involved in 25 patients (14: males, 11: females); while the maxilla was involved in 4 patients (1: males, 3: females) as shown in [Table 1].
Table 1: Jaw distribution

Click here to view


Furthermore, the left side in both jaws was the predominant side for the KCOT as shown in [Table 2].
Table 2: Anatomic location (site)

Click here to view


At the time of the presentation, nine patients showed a neurosensory disturbance, seven patients with a recurrence of KCOT, and they were treated by other methods of treatment differ from decompression, marsupialization, or enucleation. One of the patients was subjected to more than 5 different operations and the recurrence was also occured after each one of them. The radiographic studies for the 29 patients showed that 18 patients with unilocular radiolucency [Figure 2] and 11 patients with multilocular radiolucency [Figure 3].
Figure 2: Unilocular radiolucency with anterioposterior cortical and cancellous expansion

Click here to view
Figure 3: Keratocystic odontogenic tumor with multilocular radiolucency in the central region (symphyseal and parasymphyseal) of the mandible

Click here to view


In this clinical study, 9 cases showed a dehiscence in the surgical site postoperatively and 11 cases showed a neurosensory disturbance. All the 29 cases show no recurrence during the follow-up periods [Table 3].
Table 3: Treatment and outcome

Click here to view



  Discussion Top


This clinical study revealed a slight difference in frequency of the gender in males and females (51, 72% males and 48, 77% females); hence, the lesions occur about equally in both sex, while in Woolgar et al., 1987a, b series, the gender distribution of patients with solitary lesion shows a high incidence of males (62% males and 38% females). The age ranging from 12 to 62 years agrees with Meara et al., 1996 which records a wide age range for the patients.[15],[16],[17] Furthermore, this study showed that the mandible is involved far more frequently than the maxilla (86% mandible and 14% maxilla - χ2 = 29.02 P < 0.001 highly significant), and this high frequency of mandibular involvement coincide with data found in other series, 78%; 62% and 73%.[5],[18],[19] However, this study shows a slight higher frequency than the others. Regarding the relation of the anatomic location to the gender, the males were more involved than females in the mandible (48% males and 38% females), while in the maxilla, the females were more involved than males (3% males and 10% females). The predominant side in mandible and maxilla in this study is the left side (52% left side, 31% right side, and 17% middle) (χ2 = 2.845 P = 0.048 P < 0.05 significant of left, right, midline).

Patients at time of presentation were complained of swelling, sensory disturbance, and teeth mobility. Importantly, this study shows a high incidence of gingival swelling (23%) and facial swelling (12.5%) (Z-test 6.492 P = 0.01 P < 0.05 significant), this refers to the frequency of bone expansion, and this agrees with the study of Brannon, 1976, who reported a 25% frequency of bony expansion; hence, this findings differ from the existing knowledge that the KCOT grows within the medullary cavity of the jaw without bone expansion.[20],[21]

Radiographically, a unilocular radiolucent area which has a well-defined and often sclerotic border founded in 18 cases with a 62% of all cases (Z-test 7.120 P = 0.006 P < 0.05 significant), and here, we commonly depend on the panoramic radiographs (orthopantomogram); furthermore, this study agrees with Van Rensburg, 2003 who reports that although the panoramic radiograph reveals the location and expansion nature of the lesion, they did not help in determining the locularity or extent of the lesion within the jaws.[22]

The study showed that the incidence of recurrence by other methods of treatment is 14.5%, this related to the number of cases referred to our department and gave a history of previous surgical operations. Forssell, 1980, found a recurrence in 13%, 24%, and 35% during years 1, 2, and 3, respectively, for the KCOT cases which treated with enucleation or curettage and without complementary treatment.[5] Moreover, the majority of the recurrence are expected to be detected before the third postoperative year.[23]

Twenty-eight patients were treated by enucleation with peripheral ostectomy than Carnoy's solution application; moreover, to best our knowledge, there is only one series in the literature consisting of 13 patients with KCOT treated by this method.[9],[19] Furthermore, we treated only 1 case by resection and application of Carnoy's solution at the ostectomy sites and that due to the resorption of the inferior border of the mandible, cortical perforation and the involvement of the coronoid and the condyle by the KCOT. Blanas, 2000, undertook an extensive review for KCOT treatment, 14 papers were selected that met the authors' strict inclusion criteria and 578 cases were included, he concluded that simple enucleation resulted in a recurrence rate (28.7% of 387 cases), adding Carnoy's solution to the cyst cavity for 3 min after enucleation results in a recurrence rate comparable to that of resection without necessarily aggressive surgery (1.6% of 60 cases).[7] This study and by performing the peripheral ostectomy after the enucleation and then the application of Carnoy's solution to the bony defect, the recurrence rate was 0% during the follow-up period which extend from 3 to 6 years, which is the preferred period for follow-up cause the majority of the recurrence in KCOT are expected to be detected before the third postoperative year.[5],[23] Hence, this procedure appeared to be a minimal invasive procedure with the lowest recurrence rate [Figure 4].
Figure 4: (a) Preopreative radiograph for 19.year.old male patient with keratocystic odontogenic tumor at the right side of the ramus of the mandible. (arrow), date of photograph: October 2011. (b) The same case during the follow.up in January 2015, the bone continuity was restored and there was no recurrence. (it was treated in October 2011 by enucleation with peripheral ostectomy then Carnoy's solution application)

Click here to view


Furthermore, this study shows that although Carnoy's solution is a fixative agent penetrates cancellous spaces in the bone and thus devitalizes and fixes the normal and tumor cells in the bone, bone regeneration take place in the bony cavity of the jaws postoperatively and the defect in the continuity of the jaws was restored and this is one of the main advantageous results founded in this study as shown in [Figure 4],[Figure 5],[Figure 6].
Figure 5: (a) Preoperative radiograph for 47.year.old male patient with a huge unilocular radiolucency. (arrow), this case was prepared to be treated by other treatment modalities. (jaw resection) in another hospital. However, it was included in this study and treated by enucleation with peripheral ostectomy then Carnoy's solution application. (b) The bony defect in millimeter, 7. days postoperatively. (c) Follow.up of more than 3. years shows the bone regeneration at the surgical site although we use Carnoy's solution. Furthermore, it shows no recurrence. (d) The defect in millimeter during follow.up periods. (decreased)

Click here to view
Figure 6: (a) Preoperative radiograph for a female patient, operated previously and show recurrence within less than a year. (b) Panoramic radiograph after more than 2 years postoperatively, the bony defect is totally filled by regenerated bone

Click here to view


Neurosensory disturbance found in 11 cases, one of them was due to the ostectomy of the bone (bone resection) while another case shows a tender tooth with jaw pain and this case was treated by endodontic treatment to this tooth and after that, the pain was resolved, and the other 9 cases show a paresthesia of the lower lip and chin area of the operation site and we could not figure it clearly if it is related to the effect of the Carnoy's solution or if its related to the previous operation cause 9 cases show a neurosensory disturbance at the time of the presentation. Dehiscence at the surgical site was found in 9 cases postoperatively with wound break down, and this is may be attributed to the lack of support to the roof of the cavity due to bone removal from the alveolus by enucleation, peripheral ostectomy, teeth extraction or Carnoy's solution usage, this complication was treated by bony defect irrigation by normal saline (intravenous fluid) then packing the wound with BIPP impregnated gauze which changes at weekly interval (3–4 times) until secondary healing was complete. Ribeiro Júnior et al., 2007, show in their studies that the dehiscence related to Carnoy's solution occurred in 22.7% of their cases, and here, we match with this results.[12]

Apart from the case treated by resection, no facial scaring was found cause all the operations of the other cases done through intraoral approach. No fracture occurred postoperatively and all the cases treated through one-stage procedure.


  Conclusion Top


It can be concluded that the combination of treatment with enucleation and peripheral ostectomy then the application of Carnoy's solution to the bony cavity for no more than 3 minutes, appears to be efficient for treating of KCOT by diminishing the recurrence rate to 0% during the most critical period (the first 3 years) and its equal to that of the resection. The complications and morbidity originating from the application of carnoy's solution occurred less frequently and were less serious than those associated with resection.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Toller P. Origin and growth of cysts of the jaws. Ann R Coll Surg Engl 1967;40:306-36.  Back to cited text no. 1
    
2.
Philipsen HP. Keratocystic odontogenic tumour. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Lyon: IARC; 2005. p. 306-7.  Back to cited text no. 2
    
3.
Heikinheimo K, Jee KJ, Morgan PR, Nagy B, Knuutila S, Leivo I. Genetic changes in sporadic keratocystic odontogenic tumors (odontogenic keratocysts). J Dent Res 2007;86:544-9.  Back to cited text no. 3
    
4.
González-Alva P, Tanaka A, Oku Y, Yoshizawa D, Itoh S, Sakashita H, et al. Keratocystic odontogenic tumor: A retrospective study of 183 cases. J Oral Sci 2008;50:205-12.  Back to cited text no. 4
    
5.
Forssell K. The primordial cyst. A clinical and radiographic study. Proc Finn Dent Soc 1980;76:129-74.  Back to cited text no. 5
    
6.
Forssell K, Forssell H, Kahnberg KE. Recurrence of keratocysts. A long-term follow-up study. Int J Oral Maxillofac Surg 1988;17:25-8.  Back to cited text no. 6
    
7.
Blanas N, Freund B, Schwartz M, Furst IM. Systematic review of the treatment and prognosis of the odontogenic keratocyst. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:553-8.  Back to cited text no. 7
    
8.
Madras J, Lapointe H. Keratocystic odontogenic tumour: Reclassification of the odontogenic keratocyst from cyst to tumour. J Can Dent Assoc 2008;74:165.  Back to cited text no. 8
    
9.
Kaczmarzyk T, Mojsa I, Stypulkowska J. A systematic review of the recurrence rate for keratocystic odontogenic tumour in relation to treatment modalities. Int J Oral Maxillofac Surg 2012;41:756-67.  Back to cited text no. 9
    
10.
Voorsmit RA, Stoelinga PJ, van Haelst UJ. The management of keratocysts. J Maxillofac Surg 1981;9:228-36.  Back to cited text no. 10
    
11.
Stoelinga PJ. Long-term follow-up on keratocysts treated according to a defined protocol. Int J Oral Maxillofac Surg 2001;30:14-25.  Back to cited text no. 11
    
12.
Ribeiro Júnior O, Borba AM, Alves CA, Guimãraes Júnior J. Complications of Carnoy solution in the treatment of odontogenic tumors. RGO 2007;55:263-6.  Back to cited text no. 12
    
13.
Frerich B, Cornelius CP, Wiethölter H. Critical time of exposure of the rabbit inferior alveolar nerve to Carnoy's solution. J Oral Maxillofac Surg 1994;52:599-606.  Back to cited text no. 13
    
14.
Saulacic N, Stajcic Z, Stojcev Stajcic LJ, Piattelli A, Iizuka T, Lombardi T. Effects of Carnoy's solution on blood vessels of the axillary fossa of rats. Int J Oral Maxillofac Surg 2009;38:876-9.  Back to cited text no. 14
    
15.
Woolgar JA, Rippin JW, Browne RM. A comparative histological study of odontogenic keratocysts in basal cell naevus syndrome and control patients. J Oral Pathol 1987;16:75-80.  Back to cited text no. 15
    
16.
Woolgar JA, Rippin JW, Browne RM. The odontogenic keratocyst and its occurrence in the nevoid basal cell carcinoma syndrome. Oral Surg Oral Med Oral Pathol 1987;64:727-30.  Back to cited text no. 16
    
17.
Meara JG, Li KK, Shah SS, Cunningham MJ. Odontogenic keratocysts in the pediatric population. Arch Otolaryngol Head Neck Surg 1996;122:725-8.  Back to cited text no. 17
    
18.
Lam KY, Chan AC. Odontogenic keratocysts: A clinicopathological study in Hong Kong Chinese. Laryngoscope 2000;110:1328-32.  Back to cited text no. 18
    
19.
Morgan TA, Burton CC, Qian F. A retrospective review of treatment of the odontogenic keratocyst. J Oral Maxillofac Surg 2005;63:635-9.  Back to cited text no. 19
    
20.
Brannon RB. The odontogenic keratocyst. A clinicopathologic study of 312 cases. Part I. Clinical features. Oral Surg Oral Med Oral Pathol 1976;42:54-72.  Back to cited text no. 20
    
21.
Voorsmit RA. The Incredible Keratocyst. MD Dissertation, University of Nijmegen. Naarden: Los Printers; 1984.  Back to cited text no. 21
    
22.
Van Rensburg LJ, Paquette M, Morkel JA, Nortjé CJ. Correlative MRI and CT imaging of the odontogenic keratocyst: A review of 21 cases. Oral Maxillofac Surg Clin North Am 2003;15:363-82.  Back to cited text no. 22
    
23.
Apajalahti S, Hagström J, Lindqvist C, Suomalainen A. Computerized tomography findings and recurrence of keratocystic odontogenic tumor of the mandible and maxillofacial region in a series of 46 patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;111:e29-37.  Back to cited text no. 23
    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6]
 
 
    Tables

  [Table 1], [Table 2], [Table 3]



 

Top
 
 
Search
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)  

 
  In this article
   Abstract
  Introduction
   Materials and Me...
  Results
  Discussion
  Conclusion
   References
   Article Figures
   Article Tables

 Article Access Statistics
    Viewed1508    
    Printed30    
    Emailed0    
    PDF Downloaded262    
    Comments [Add]    

Recommend this journal